Soluble immunologic products in scleroderma sera
- 1 January 1991
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 58 (1) , 139-144
- https://doi.org/10.1016/0090-1229(91)90155-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interleukin-2 in Scleroderma: Correlation of Serum Level with Extent of Skin Involvement and Disease DurationAnnals of Internal Medicine, 1989
- A functional dichotomy in CD4+ T lymphocytesImmunology Today, 1988
- Effect of lymphotoxin and tumor necrosis factor on endothelial and connective tissue cell growth and functionClinical Immunology and Immunopathology, 1988
- Induction of Dermal Subcutaneous Inflammation by Recombinant Cachectin/Tumor Necrosis Factor (TNFα) in the MouseJournal of Investigative Dermatology, 1988
- Enhanced production of interleukin‐2 in patients with progressive systemic sclerosis. hyperactivity of cd4‐positive t cells?Arthritis & Rheumatism, 1988
- Lymphocytes in the skin of patients with progressive systemic sclerosisArthritis & Rheumatism, 1984
- SclerodermaArchives of Dermatology, 1983
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Cellular infiltrates in scleroderma skinArthritis & Rheumatism, 1977
- Pathologic observations concerning the cutaneous lesion of progressive systemic sclerosis: An electron microscopic histochemical and immunohistochemical studyArthritis & Rheumatism, 1960